US6315173B1 - Valve for aerosol container - Google Patents

Valve for aerosol container Download PDF

Info

Publication number
US6315173B1
US6315173B1 US09709084 US70908400A US6315173B1 US 6315173 B1 US6315173 B1 US 6315173B1 US 09709084 US09709084 US 09709084 US 70908400 A US70908400 A US 70908400A US 6315173 B1 US6315173 B1 US 6315173B1
Authority
US
Grant status
Grant
Patent type
Prior art keywords
valve
drug
metering
suspension
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09709084
Inventor
Patrick Di Giovanni
Cheryl Vanessa Rogerson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date
Family has litigation

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/44Valves specially adapted therefor; Regulating devices
    • B65D83/52Valves specially adapted therefor; Regulating devices for metering
    • B65D83/54Metering valves ; Metering valve assemblies
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/38Details of the container body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Abstract

Valve for an aerosol container for dispensing a suspension of a substance in a liquid propellant contained therein The valve comprises a valve body (1) having at least one orifice (16) to allow a quantity of the suspension to pass from the container into the valve. The valve further comprises a ring (18) disposed around the valve body (1), the ring being positioned below the at least one orifice to reduce the volume of suspension that can be accommodated within the container below the at least one orifice when the container is orientated with the valve at the bottom, the ring having at least one portion of reduced axial thickness to provide a trough (19) around the valve body below the at least one orifice.

Description

This application is a continuation of U.S. patent application Ser. No. 09/331,801 filed Sep. 13, 1999, now U.S. Pat. No. 6,170,717, which is a 371 of PCT/EP97/07224 filed Dec. 23, 1997.

This invention relates to a valve for an aerosol container with the aid of which a quantity of the contents thereof can be dispensed. The invention has particular application to the dispensing of metered doses of medicaments, though it is applicable to the dispensing of aerosols generally.

In dispensing a solid in aerosol form it is common to use what is known as a suspension aerosol. This involves the use of a liquid propellant in which a solid to be dispensed is suspended. There is inevitably some difference, however slight, between the respective specific gravities of the propellant and the solid to be dispensed, which means that, with the passage of time and in the absence of other overriding interactions, the two components tend to separate in the container, with a lighter component going to the top or a heavier component going to the bottom over time.

In some pharmaceutical aerosols the particles of medicament are more dense than the propellant and hence the particles tend to sediment out to the bottom of the container. This phenomenon may be accentuated by the additional structuring of the medicament presentation necessary to enhance its physical stability, for example by controlled flocculation thereof. Controlled flocculation of the suspension may increase the effective particle size in dispersion from less than 10 μm to greater than 100 μm . A squared dependency on particle radius will directly increase the sedimentation rate in such circumstances.

Users of suspension aerosols are always instructed before use to shake the container well. However, even a short interval between the conclusion of the shaking and the act of dispensing a charge from the aerosol is sufficient to allow some sedimentation to occur. This represents a particular problem where the suspended material is a medicament, since it can result in the patient receiving a dose which, although of the correct volume, contains either too little or too much of the medicament.

This problem has been found to be particularly acute in the development of CFC-free aerosol formulations using propellant 1,1,1,2-tetrafluoroethane, also known as HFA134a, which is less dense than conventional CFC containing propellants. With some aerosol drug formulations using this propellant, when the container is orientated with the valve at the bottom, the drug particles rapidly sediment onto and around the valve, and with vibration caused by, for example, transportation, find their way into the valve body. The trapped drug is then not fully dispensed, even on shaking due to the confinement of the valve body, and on discharge of valve actuation the trapped drug enters the metering chamber which leads to a high drug content in the dose delivered by the following actuation. This problem is especially pronounced where the drug is fluticasone propionate.

UK Patent No. 2195986 describes an aerosol valve wherein the pick-up point, i.e. the point at which liquid passes from the interior of the container into the sampling chamber of the valve, is at a location which, when the container is orientated with the valve at the bottom, is spaced an appreciable vertical distance from the nearest substantially horizontal surface. Whilst this valve ensures that the liquid entering the metering chamber following a dispensing operation comes from above the nearest region where sedimented drug particles might gather, any sedimenting drug particles that might be drawn into the sampling chamber together with any drug particles that sediment out of the suspension within the sampling chamber tend to be trapped and are not dispensed on shaking. Furthermore, by deliberately placing the pick-up point appreciably higher than the lowest point in the container, a significant quantity of the contents of the container cannot be dispensed, which results in considerable wastage.

It is an object to provide a valve which alleviates these problems.

According to the present invention there is provided a valve for an aerosol container for dispensing a suspension of a substance in a liquid propellant contained herein, the valve comprising a valve body having at least one orifice to allow a quantity of the suspension to pass from the container into the valve, characterised in that the valve further comprises a ring disposed around the valve body, the ring being positioned below the at least one orifice to reduce the volume of suspension that can be accommodated within the container below the at least one orifice when the container is orientated with the valve at the bottom, the ring having at least one portion of reduced axial thickness to provide a trough around the valve body below the at least one orifice.

By providing a ring below the at least one orifice to reduce the volume of suspension that can be accommodated within the container below the orifice(s) when the container is orientated with the valve at the bottom, it ensures that most of the contents of the container may be dispensed to reduce wastage, while the trough around the valve body below the orifice(s) provided by the at least one portion of reduced axial thickness serves to accommodate any drug particle sediment so ensuring that the suspension entering the sampling chamber comes from above the region where any sedimented drug particles might gather.

Preferably, the valve is a metering valve comprising a metering chamber, a sampling chamber, a transfer passage through which a quantity of suspension can pass from the sampling chamber to the metering chamber, and a valve stem having a dispensing passage through which a dose of suspension can be dispensed from the metering chamber, the valve stem being slideably moveable within the valve body such that in a first position the dispensing passage is isolated from the metering chamber and the metering chamber is in communication with the sampling chamber via the transfer passage, and in a second position the dispensing passage is in communication with the metering chamber and the transfer passage is isolated from the metering chamber the valve body having a plurality of orifices to allow a quantity of the suspension to pass from the container into the sampling chamber.

By providing a valve body having a plurality of orifices to allow the suspension to pass from the container into the sampling chamber, the suspension may flow freely through the sampling chamber so allowing the suspension contained within the sampling chamber and the container to mix when the container is shaken and so disperse any drug particle sediment within the sampling chamber.

Suitably the orifices are slots extending in a substantially axial direction. Preferably the slots extend substantially-the entire axial length of the sampling chamber.

By providing slots the length of the sampling chamber the suspension may flow freely through the entire sampling chamber, so allowing maximum dispersion of drug particle sediment within the sampling chamber.

Preferably there are more than two slots.

Suitably the ring further comprises a seat to locate a gasket between the container and valve for sealing the container.

By providing a seat on the ring to locate the gasket, the gasket is reduced in size, and the area of gasket exposed to the contents of the container is also reduced.

Suitably the ring further comprises a plurality of vanes separated by slots at its periphery and extending substantially upwardly when the container is orientated with the valve at the bottom.

By providing vanes separated by slots at the periphery of the ring the suspension is made to flow around the vanes and through the slots when the container is shaken, and the resulting swirling motion of the suspension helps to disperse any drug particle sediment on and around the ring.

Suitably the substance to be dispersed is a medicament suspended in liquefied HFA134a. Preferably the medicament is fluticasone propionate.

The invention will now be described further with reference to the accompanying drawings in which:

FIG. 1 in a section through a metering valve according to a first embodiment of the invention;

FIG. 2 is a section through a metering valve according to a second embodiment of the invention; and

FIG. 3 is a partly cut away perspective view of a ring for use with a valve according to the invention.

The valve according to a first embodiment of the invention as shown in FIG. 1 comprises a valve body 1 sealed in a ferrule 2 by means of crimping, the ferrule itself being set on the neck of a container (not shown) with the interposition of a gasket 3 in a well-known manner. The container is filled with a suspension of a medicament in liquid propellant HFA134a. Medicaments suitable for this purpose are, for example for the treatment of respiratory disorders such as asthma, bronchitis, chronic obstructive pulmonary diseases and chest infections. Additional medicaments may be selected from any other suitable drug useful in inhalation therapy and which may be presented as a suspension. Appropriate medicaments may thus be selected from, for example, analgesics, e.g. codeine, dihydromorphine, ergotamine, fentanyl or morphine; anginal preparations, e.g. diltiazem; antiallergics, e.g. cromoglycate, ketotifen or neodocromil; antiinfectives e.g. cephalosporins, penicillins, streptomycin, sulphonamides, tetracyclines and pentamidine.; antihistamines, e.g. methapyrilene; anti-inflammatories e.g. fluticasone propionate, beclomethasone dipropionate, flunisolide, budesonide, or triamcinolone acetonide; antitussives, e.g. noscapine; bronchodilators, e.g. salmeterol, salbutamol, ephedrine, adrenaline, fenoterol, formoterol, isoprenaline, metaproterenol, phenylephrine, phenylpropanolamine, pirbuterol, reproterol, rimiterol, terbutaline, isoetharine, tulobuterol orciprenaline, or (−)-4-amino-3,5-dichloro-α-[[[6-[2-(2-pyddinyl)ethoxy]-hexyl]amino]methyl] benzenemethanol; diuretics, e.g. amiloride; anticholinergics e.g. ipratropium, atropine or oxitropium; hormones, e,g, cortisone, hydrocortisone or prednisolone; xanthines e.g. aminophylline, choline theophyllinate, lysine theophyllinate or theophylline and therapeutic proteins and peptides, e.g. insulin or glucagon. It will be clear to a person skilled in the art that, where appropriate, the medicaments may be used in the form of salts (e.g. as alkali metal or amine salts or as acid addition salts) or as esters (e.g. lower alkyl esters) or as solvates (e.g. hydrates) to optimise the activity and/or stability of the medicament. Preferred medicaments are salbutamol, salbutamol sulphate, salmeterol, salmeterol xinafoate, fluticasone propionate, beclomethasone dipropionate and terbutaline sulphate. It is to be understood that the suspension of medicament may consist purely of one or more active ingredients.

The valve body 1 is formed at its lower part with a metering chamber 4,and its upper part with a sampling chamber 5 which also acts as a housing for a return spring 6.The words “upper” and “lower” are used for the container when it is in a use orientation with the neck of the container and valve at the lower end of the container which corresponds to the orientation of the valve as shown in FIG. 1. Inside the valve body 1 is disposed a valve stem 7, a part 8 of which extends outside the valve through lower stem seal 9 and ferrule 2.The stem part 8 is formed within an inner axial or longitudinal canal 10 opening at the outer end of the stem and in communication with a radial passage 11.

The upper portion of stem 7 has a diameter such that it can pass slideably through an opening in an upper stem seal 12 and will engage the periphery of that opening sufficiently to provide a seal. Upper stem seal 12 is held in position against a step 13 formed in the valve body I between the lower and upper parts by a sleeve 14 which defines the metering chamber 4 between lower stem seal 9 and upper stem seal 12.The valve stem 7 has a passage 15 which, when the stem is in the inoperative positive shown, provides a communication between the metering chamber 4 and sampling chamber 5, which itself communicates with the interior of the container via orifices 16 formed in the side of the valve body 1. The orifices 16 comprise three slots arranged equi-angularly around the valve body 1 and extending in an axial direction with respect thereto, each slot having a width of approximately 1 mm and a length slightly less than the length of the sampling chamber 5 so that the suspension within the container can flow freely through the entire sampling chamber 5.

Valve stem 7 is biased downwardly to the inoperative position by return spring 6 and is provided with a shoulder 17 which abuts against lower stem seal 9.In the inoperative position as shown in FIG. 1 shoulder 17 abuts against lower stem seal 9 and radial passage 11 opens below lower stem seal 9 so that the metering chamber 4 is isolated from canal 10 and suspension inside cannot escape.

A ring 18 is disposed around the valve body below the slots, and is formed with a number of portions of reduced axial thickness giving a “U” shaped cross section extending in a radial direction so as to form a number of troughs 19 around the valve body. As seen in FIGS. 1 and 3,the ring is formed as a separate component made of nylon or any other suitable material, and has an inner annular contacting rim of a diameter suitable to provide a friction fit over the upper part of valve body 1, the ring seating against step 13 below the slots 16. However, the ring 18 may alternatively be formed as an integrally moulded part of valve body 1.

The outer wall of the ring is extended in an axial direction and is formed with a number of equi-angularly spaced slots to create vanes 20 which extend upwards from the lower part of the ring, as best seen in FIG. 3. In the ring depicted in FIG. 3, there are six slots and six vanes, though not all are shown in view of the cut away portion. However, it will be clear that more or fewer slots and vanes could be used. The lower part of the ring is further provided with a seat 21 for gasket 3 which helps to locate the gasket in the correct position during assembly and also allows the inner diameter of the gasket to be increased, thereby reducing the mass of the gasket and the area of gasket exposed to the material within the container. This can offer a significant advantage where there are problems with impurities being leached out of the gasket into the material contained.

To use the device, the container is shaken to homogenise the suspension within the container. As the container is shaken, the suspension in the container flows freely through the slots 16 in the sampling chamber 5, so ensuring that the suspension in the sampling chamber is thoroughly mixed with the suspension in the container. Not only does this ensure homogeneity of suspension within the container and sampling chamber, but the flow of suspension also serves to disperse any drug particle sediment that may have precipitated out of suspension within the sampling chamber 5. Shaking of the container also causes the suspension to flow around the vanes 20 and the resulting turbulence and swirling motion of the suspension helps to disperse any drug particle sediment on and around the ring.

The user then depresses the valve stem 7 against the force of the spring 6. When the valve stem is depressed, both ends of the passage 15 come to lie on the side of upper stem seal 12 remote from the metering chamber 4. Thus a dose is metered within the metering chamber. Continued depression of the valve stem will move the radial passage 11 into the metering chamber 4 while the upper stem seal 12 seals against the valve stem body. Thus, the metered dose can exit through the radial passage 11 and the outlet canal 10.

Releasing the valve stem causes it to return to the illustrated position under the force of the spring 6. The passage 15 then once again provides communication between the metering chamber 4 and the sampling chamber 5. Accordingly, at this stage liquid passes under pressure from the container through slots 16, through the passage 15 and thence into the metering chamber 4 to fill it.

It can be seen that in the operative orientation of the container and valve as shown, the “U” shaped configuration of the ring 18 around the valve body provides a trough 19 which lies an appreciable distance below the slots 16.The trough serves to accommodate any drug particle sediment that fails to be re-dispersed into suspension, and thus ensures that the suspension entering the sampling chamber 5 through the slots 16 is drawn from a region containing homogenous suspension which is free of drug particle sediment.

The ring 18 further serves to reduce the volume of suspension that can be accommodated within the container below the slots 16. This ensures that most of the contents of the container may be dispensed, the only quantity of suspension that need be wasted corresponding to the reduced volume remaining below the slots after the suspension level has fallen below the level from which it may enter the sampling chamber.

Tables 1 and 2 present end of life actuation weights in mg delivered from two sets of five inhalers each. Both tables show data derived from inhalers containing the equivalent of 160 actuations of a suspension of fluticasone propionate in liquefied HFA134a with a target delivery of 120 actuations plus a 40 actuation overfill to allow for ullage and leakage. Only data from actuation number 115 is shown as the data for both sets of inhalers is consistent up to this point. Table 1 shows data from the first set of five conventional inhalers having valves without a ring. Table 2 shows data from the second set of five inhalers having valves with a ring according to the invention:

TABLE 1
End of Life Actuation weights for valve without ring
Actuation Actuation weights (mg)
No. Inhaler 1 Inhaler 2 Inhaler 3 Inhaler 4 Inhaler 5
115 61 60 62 62 61
116 62 62 62 61 61
117 61 60 62 61 60
118 61 61 62 60 60
119 42 60 62 45 31
120 61 61 62 61 62
121 60 59 61 62 60
122 60 59 61 61 60
123 62 61 62 61 61
124 63 61 62 61 60
125 62 42 47 47 59
126 62 59 64 63 60
127 49 61 53 42 37
128 61 61 63 61 62
129 63 57 39 63 63
130 63 62 63 63 62
131 60 41 34 38 45
132 62 61 61 60 59
133 44 43 39 49 61
134 60 62 58 62 60
135 32 60 17 26 44
136 58 61 60 59 61
137 49 54 58 51 59
138 48 45 34 59 59
139 25 16 14 29 16
140 37 18 20 5 12
141 6 8 5 7 18
142 47 23 30 27 38
143 10 29 23 15 22
144 9 16 18 31 36
145 30 37 29 33 48
146 42 41 32 30 46

TABLE 2
End of Life Actuation weights for valve with ring
Actuation Actuation weights (mg)
No. Inhaler 1 Inhaler 2 Inhaler 3 Inhaler 4 Inhaler 5
115 60 61 61 60 62
116 62 61 61 61 63
117 61 60 60 60 61
118 61 61 61 60 62
119 60 59 60 60 61
120 60 61 60 60 62
121 60 59 60 59 62
122 60 60 59 59 60
123 61 61 61 61 61
124 61 60 61 61 63
125 61 60 60 59 31
126 61 60 61 60 62
127 61 59 61 60 61
128 61 61 61 60 63
129 62 58 61 61 57
130 62 61 61 61 63
131 60 61 61 60 60
132 61 60 61 61 62
133 61 61 61 60 62
134 61 61 61 61 62
135 61 60 60 60 62
136 61 60 60 60 62
137 59 60 59 58 60
138 59 59 59 59 60
139 59 55 59 60 55
140 31 61 61 59 60
141 25 48 61 60 33
142 61 60 61 60 60
143 21 9 23 20 26
144 17 25 32 26 25
145 44 32 36 25 35
146 17 9 26 19 28

From Table 1 it can be seen that actuation weight starts to become fairly inconsistent after actuation number 124 for valves without the ring, whereas from Table 2 it can be seen that actuation weight remains fairly consistent up to actuation number 137 and thereafter rapidly tails off for those valves according to the invention incorporating the ring. It is therefore clear that the ring has a significant effect on end of life actuation weight delivered.

A valve according to a second embodiment of the invention as shown in FIG. 2 is a variant of the valve shown in FIG. 1 in which corresponding elements have been given the same reference numerals as are used in FIG. 1. The main difference between the two embodiments is that the valve of FIG. 2 uses a different design of valve body 1 which has a single orifice 26 allowing communication between sampling chamber 5 and the interior of the container. The valve is operated in exactly the same manner as described with respect to the valve shown in FIG. 1. The valve shown in FIG. 2 might be used with suspensions wherein the problem of sedimentation within the sampling chamber is not so acute but wherein sedimentation around the valve nonetheless remains a problem.

Table 3 demonstrates the improved dose reproducibility achieved using a valve according to the first embodiment of the invention with a body having three slots as shown in FIG. 1 compared to a valve according to the second embodiment of the invention with a body having a single orifice as shown in FIG. 2 when used to dispense a suspension of fluticasone propionate in liquefied HFA134a. The figures given in the table are average dose weights dispensed from at least five inhalers. For each inhaler, doses from two actuations were measured prior to subjecting each inhaler to a vibration test to simulate the effects of transportation, after which doses from two further actuations were measured:

TABLE 3
Effect of vibration on dose delivered
Dose (μg) prior to vibration Dose (μg) after vibration
Valve type 1st actuation 2nd actuation 1st actuation 2nd actuation
Body with 233 246 217 688
single
orifice
Body with 288 285 275 317
three slots

The data presented in Table 3 clearly shows that the characteristics of extreme dose variability experienced with valves having a single sampling point (orifice), which is due to the highly sedimentary nature of fluticasone propionate in liquefied HFA134a, are considerably reduced with the three slot body.

It will be understood that the present disclosure is for the purpose of illustration only and the invention extends to modifications, variations and improvements thereto.

Claims (39)

What is claimed is:
1. A metering valve comprising:
a valve body;
a metering chamber;
a valve stem;
one or more stem seals;
at least one orifice in the valve body; and,
a ring having a trough disposed around the valve body, wherein the ring further includes an annular wall interrupted with a plurality of slots forming a plurality of vanes, wherein, upon shaking of the valve, the suspension flows around the plurality of vanes assisting in dispersion of drug particles in the suspension;
wherein the metering valve is suitable for dispensing a suspension of drug particles in a liquid propellant, and,
wherein the drug is a member selected from the group consisting of salmeterol, salbutamol, formoterol, ipratroprium, fluticasone, beclomethasone, budesonide, terbutaline, salts, esters and solvates thereof, and combinations thereof.
2. The metering valve of claim 1 including an upper stem seal and a lower stem seal.
3. The metering valve of claim 2, wherein the ring further includes a seat adapted to accommodate a gasket to seal the container.
4. The metering valve of claim 1, wherein the at least one orifice is at least one slot extending substantially axially.
5. The metering valve of claim 1 further including a sampling chamber, wherein the at least one slot extends substantially the axial length of the sampling chamber.
6. The metering valve of claim 5 including more than two slots.
7. The valve of claim 1 including more than 2 slots and more than 2 vanes.
8. The valve of claim 1 wherein the drug is fluticasone propionate.
9. The metering valve of claim 1, wherein the ring is further capable of reducing the volume of suspension accompanied within a container below the at least one orifice when the container is oriented with the valve at the bottom, wherein the trough is circumferential around the valve body.
10. The metering valve of claim 1 comprising 6 slots and 6 vanes.
11. The metering valve of claim 1 wherein the drug is a combination of a salt, ester or solvate of salmeterol and fluticasone.
12. The metering valve of claim 11, wherein the drug is a combination of salmeterol xinafoate and fluticasone propionate.
13. The metering valve of claim 1, wherein the drug is salmeterol xinafoate.
14. The metering valve of claim 1, wherein the drug is salbutamol sulfate.
15. The metering valve of claim 1, wherein the drug is beclomethasone dipropionate.
16. The metering valve of claim 1, wherein the drug is a combination of ipratroprium bromide and salmeterol xinafoate.
17. The metering valve of claim 1, wherein the ring is constructed from nylon.
18. The metering valve of claim 1, wherein the ring is adapted to be friction fitted with the valve body.
19. The metering valve of claim 18, wherein the ring includes an inner annular contacting rim adapted to friction fitted to the valve body.
20. The metering valve of claim 1, wherein the propellant is HFA 134A.
21. A metering valve comprising:
a valve body;
a means for metering a suspension of drug particles in a liquid propellant;
a valve stem;
one or more means for sealing the valve stem;
at least one orifice in the valve body;
a ring disposed around the valve body and positioned below the at least one orifice;
a means, below the at least one orifice, for collecting drug particle sediment; and,
means for assisting in the dispersion of the drug particles in the liquid propellant,
wherein the metering valve is suitable for dispensing the suspension, and
wherein the drug is a member selected from the group consisting of salmeterol salbutamol, formoterol, ipratroprium, fluticasone, beclomethasone, budesonide, terbutaline, salts, esters and solvates thereof, and combinations thereof.
22. A metering valve comprising:
a valve body;
at least one orifice,
a sampling chamber having an axial length,
a ring having a trough and an annular wall interrupted with a plurality of slots and a plurality of vanes, the ring disposed around the valve body,
a metering chamber,
a transfer passage between the sampling chamber and the metering chamber,
a valve stem,
one or more stem seals; and,
a dispensing passage within the valve stem,
wherein the valve stem is slibeably moveable within the valve body such that in a first position the dispensing passage is isolated from the metering chamber and the metering chamber is in communication with the sampling chamber via the transfer passage,
wherein the valve stem is slideably moveable within the valve body such that in a second position the dispensing passage is in communication with the metering chamber and the transfer passage is isolated from the metering chamber,
wherein the metering valve is suitable for dispensing a suspension of drug particles in a liquid propellant, and
wherein the drug is a member selected from the group consisting of salmeterol, salbutamol, formoterol, ipratroprium, fluticasone, beclomethasone, budesonide, terbutaline, salts, esters and solvates thereof, and combinations thereof.
23. A metered dose inhaler comprising:
an aerosol container containing a suspension of drug particles in a liquid propellant in communication with
a valve comprising:
a valve body;
a metering chamber;
a valve stem;
one or more stem seals;
at least one orifice in the valve body to allow a quantity of the suspension to pass from the container into the valve; and,
a ring having a trough disposed around the valve body, wherein the ring further includes an annular wall interrupted with a plurality of slots forming a plurality of vanes, wherein, upon shaking of the aerosol container, the suspension flows around the plurality of vanes assisting in dispersion of drug particles in the suspension, and,
wherein the drug is a member selected from the group consisting of salmeterol, salbutamol, formoterol, ipratroprium, fluticasone, beclomethasone, budesonide, terbutaline, salts, esters and solvates thereof, and combinations thereof.
24. The metered dose inhaler of claim 23 wherein the drug is salmeterol xinafoate.
25. The metered dose inhaler of claim 23 wherein the drug is salbutamol sulphate.
26. The metered dose inhaler of claim 23 wherein the drug is beclomethasone dipropionate.
27. The metered dose inhaler of claim 23 wherein the drug is a combination of salmeterol xinafoate and fluticasone propionate.
28. The metered dose inhaler of claim 23 wherein the drug is a combination of a salt, ester or solvate of salmeterol and ipratroprium.
29. The metered dose inhaler of claim 28 wherein the drug is a combination of salmeterol xinafoate and ipratroprium bromide.
30. The metered dose inhaler of claim 23 wherein the propellant is 1,1,1,2-tetrafluoroethane.
31. The metered dose inhaler of claim 23, wherein the at least one orifice is at least one slot extending substantially axially.
32. The metered dose inhaler of claim 23 further including a sampling chamber, wherein the at least one slot extends substantially the axial length of the sampling chamber.
33. The metered dose inhaler of claim 23 including more than two slots.
34. The metered dose inhaler of claim 23, wherein the ring further includes a seat adapted to accommodate a gasket to seal the container.
35. The metered dose inhaler of claim 23 including more than 2 slots and more than 2 vanes.
36. The metered dose inhaler of claim 23 wherein the ring is further capable of reducing the volume of suspension accompanied within the container below the at least one orifice when the container is oriented with the valve at the bottom, wherein the trough is circumferential around the valve body, and wherein the trough is provided by a portion of reduced axial thickness in the ring below the at least one orifice.
37. The metered dose inhaler of claim 23 wherein the drug is a member selected from the group consisting of formoterol, terbutaline, and salts, esters and solvates thereof.
38. The metered dose inhaler of claim 23 comprising 6 slots and 6 vanes.
39. A metered dose inhaler comprising:
a means for containing a suspension of drug particles in a liquid propellant in communication with
a valve comprising:
a valve body;
a means for metering the suspension;
a valve stem;
one or more means for sealing the valve stem;
at least one orifice in the valve body to allow a quantity of the suspension to pass from the containing means into the valve; and,
a ring having a means, disposed around the valve body, for collecting drug particle sediment,
wherein the ring further includes an annular wall interrupted with a plurality of slots forming a plurality of vanes, wherein, upon shaking of the containing means, the suspension flows around the plurality of vanes assisting in dispersion of drug particles in the suspension, and,
wherein the drug is a member selected from the group consisting of salmeterol, salbutamol, formoterol, ipratroprium, fluticasone, beclomethasone, budesonide, terbutaline, salts, esters and solvates thereof, and combinations thereof.
US09709084 1996-12-27 2000-11-10 Valve for aerosol container Expired - Lifetime US6315173B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9626960A GB9626960D0 (en) 1996-12-27 1996-12-27 Valve for aerosol container
GB9626960 1996-12-27

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09957916 US6510969B2 (en) 1996-12-27 2001-09-21 Valve for aerosol container
US10347092 US6966467B2 (en) 1996-12-27 2003-01-17 Valve for aerosol container
US11107517 US7350676B2 (en) 1996-12-27 2005-04-15 Valve for aerosol container

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
US09331801 Continuation
PCT/EP1997/007224 Continuation WO1998029321A1 (en) 1996-12-27 1997-12-23 Valve for aerosol container
US09331801 Continuation US6170717B1 (en) 1996-12-27 1997-12-23 Valve for aerosol container

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09957916 Continuation US6510969B2 (en) 1996-12-27 2001-09-21 Valve for aerosol container

Publications (1)

Publication Number Publication Date
US6315173B1 true US6315173B1 (en) 2001-11-13

Family

ID=10805066

Family Applications (5)

Application Number Title Priority Date Filing Date
US09331801 Expired - Lifetime US6170717B1 (en) 1996-12-27 1997-12-23 Valve for aerosol container
US09709084 Expired - Lifetime US6315173B1 (en) 1996-12-27 2000-11-10 Valve for aerosol container
US09957916 Expired - Lifetime US6510969B2 (en) 1996-12-27 2001-09-21 Valve for aerosol container
US10347092 Expired - Lifetime US6966467B2 (en) 1996-12-27 2003-01-17 Valve for aerosol container
US11107517 Expired - Lifetime US7350676B2 (en) 1996-12-27 2005-04-15 Valve for aerosol container

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09331801 Expired - Lifetime US6170717B1 (en) 1996-12-27 1997-12-23 Valve for aerosol container

Family Applications After (3)

Application Number Title Priority Date Filing Date
US09957916 Expired - Lifetime US6510969B2 (en) 1996-12-27 2001-09-21 Valve for aerosol container
US10347092 Expired - Lifetime US6966467B2 (en) 1996-12-27 2003-01-17 Valve for aerosol container
US11107517 Expired - Lifetime US7350676B2 (en) 1996-12-27 2005-04-15 Valve for aerosol container

Country Status (11)

Country Link
US (5) US6170717B1 (en)
EP (3) EP1415934B1 (en)
JP (2) JP3549543B2 (en)
KR (1) KR100541308B1 (en)
CN (1) CN1094876C (en)
CA (2) CA2391111C (en)
DE (6) DE69711710T2 (en)
DK (3) DK1415934T3 (en)
ES (3) ES2175515T3 (en)
GB (1) GB9626960D0 (en)
WO (1) WO1998029321A1 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6510969B2 (en) * 1996-12-27 2003-01-28 Smithkline Beecham Corporation Valve for aerosol container
US6607106B2 (en) * 2001-07-09 2003-08-19 Conagra Dairy Food Research Center Aerosol valve
US6843392B1 (en) 1999-08-07 2005-01-18 Smith Kline Beecham Valve with a valve stem wiper
US20050173466A1 (en) * 2001-12-13 2005-08-11 David Goujon Fluid product dispensing valve and fluid product dispensing device comprising same
US20050230451A1 (en) * 2004-04-19 2005-10-20 Vanstaan Valery H In-can fuel cell metering valve
US20060076010A1 (en) * 2002-12-18 2006-04-13 King Michael L Drug delivery system with vented mouthpiece
US20060243753A1 (en) * 2003-07-02 2006-11-02 David Goujon Control valve for a fluid product dispenser and a fluid product dispenser comprising such a valve
US20070053843A1 (en) * 2003-10-28 2007-03-08 Dawson Michelle L Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
US20070183982A1 (en) * 2006-02-09 2007-08-09 Erhard Berkel Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant
WO2008049107A1 (en) * 2006-10-19 2008-04-24 3M Innovative Properties Company Metered dose valves and dispensers
US20080110953A1 (en) * 2004-04-19 2008-05-15 Gibson Eric S Interchangeable adapter for in-can and on-can fuel cells
US20090029901A1 (en) * 2005-02-10 2009-01-29 Marian Wood-Kaczmar Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations
US20090047351A1 (en) * 2005-02-10 2009-02-19 Stephen Newman Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
WO2012041031A1 (en) 2010-09-28 2012-04-05 健乔信元医药生技股份有限公司 Compound composition for inhalation used for treating asthma
US8172827B2 (en) 2003-05-13 2012-05-08 Innovative Pulmonary Solutions, Inc. Apparatus for treating asthma using neurotoxin
US20120168463A1 (en) * 2009-12-01 2012-07-05 Toyo Aerosol Industry Co., Ltd. Aerosol device for allocation of plurality of fluids
WO2013026269A1 (en) 2011-03-17 2013-02-28 益得生物科技股份有限公司 Method for preparing metered dose sprayed inhaler for treating respiratory disease
US20130161352A1 (en) * 2010-08-16 2013-06-27 Bayer Intellectual Property Gmbh Dispensing module
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US20130320061A1 (en) * 2008-05-16 2013-12-05 Max Co., Ltd. Fuel cartridge and gas-combustion type driving tool
US20140008389A1 (en) * 2010-12-22 2014-01-09 Satoshi Mekata Valve assembly and aerosol container equipped with the same, and aerosol product and process for production thereof
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9545487B2 (en) 2012-04-13 2017-01-17 Boehringer Ingelheim International Gmbh Dispenser with encoding means
US20170144285A1 (en) * 2015-11-25 2017-05-25 Illinois Tool Works Inc. Adapter for combustion tool fuel cells
US9682202B2 (en) 2009-05-18 2017-06-20 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
US9724482B2 (en) 2009-11-25 2017-08-08 Boehringer Ingelheim International Gmbh Nebulizer
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
US9757750B2 (en) 2011-04-01 2017-09-12 Boehringer Ingelheim International Gmbh Medicinal device with container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
US10004857B2 (en) 2013-08-09 2018-06-26 Boehringer Ingelheim International Gmbh Nebulizer
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US10099022B2 (en) 2014-05-07 2018-10-16 Boehringer Ingelheim International Gmbh Nebulizer
US10124129B2 (en) 2008-01-02 2018-11-13 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
US10124125B2 (en) 2009-11-25 2018-11-13 Boehringer Ingelheim International Gmbh Nebulizer

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7278590B1 (en) 1992-02-24 2007-10-09 Homax Products, Inc. Systems and methods for applying texture material to ceiling surfaces
GB9918573D0 (en) * 1999-08-07 1999-10-06 Glaxo Group Ltd Valve
DE19962664C2 (en) * 1999-12-23 2003-01-30 Helvoet Pharma A closure device for a vacuum sample collector
GB2361229A (en) * 2000-04-14 2001-10-17 Presspart Mfg Ltd Metering valve
JP2002332081A (en) * 2001-05-10 2002-11-22 Bioactis:Kk Gas spray valve and injection tool used for gas injection
GB2384198B (en) 2002-01-18 2005-03-02 Profile Drug Delivery Ltd Nebulizer metering
US6832704B2 (en) 2002-06-17 2004-12-21 Summit Packaging Systems, Inc. Metering valve for aerosol container
FR2844254B1 (en) * 2002-09-10 2006-02-10 Valois Sa A fluid dispenser valve and fluid dispenser device comprising such a valve
GB0226021D0 (en) 2002-11-07 2002-12-18 Corporate Intellectual Propert A container
GB0301366D0 (en) * 2003-01-21 2003-02-19 Glaxo Group Ltd A fixation device
GB0302812D0 (en) * 2003-02-07 2003-03-12 Wickham Mark D Metering valves for dispensers
US7500621B2 (en) 2003-04-10 2009-03-10 Homax Products, Inc. Systems and methods for securing aerosol systems
EP1618049B1 (en) * 2003-04-30 2009-12-23 Consort Medical PLC Metering valve
US8523025B2 (en) * 2003-10-09 2013-09-03 Mwv Slatersville, Llc Dispensing closure having flow modulator and syneresis capture
JP4578185B2 (en) * 2003-12-12 2010-11-10 大正製薬株式会社 Microconidia doser for aerosol containers
US20050161531A1 (en) 2004-01-28 2005-07-28 Greer Lester R.Jr. Texture material for covering a repaired portion of a textured surface
EP1773675B1 (en) * 2004-06-22 2010-04-07 The Procter and Gamble Company Ergonomic closure
US7677420B1 (en) 2004-07-02 2010-03-16 Homax Products, Inc. Aerosol spray texture apparatus for a particulate containing material
JP2006054055A (en) * 2004-07-16 2006-02-23 Tokai Corp Connecting structure of fuel cartridge for fuel cell
GB2417024B (en) * 2004-08-11 2007-01-03 Bespak Plc Improvements in metering valves for dispensers
GB2417479B (en) 2004-08-26 2006-09-13 Bespak Plc Improvements in metering valves for pressurised dispensing containers
US7487893B1 (en) 2004-10-08 2009-02-10 Homax Products, Inc. Aerosol systems and methods for dispensing texture material
US7134579B2 (en) * 2004-11-15 2006-11-14 Ultramotive Corporation RTV silicone spray system
EP1962931A2 (en) * 2005-12-21 2008-09-03 Glaxo Group Limited Aerosol canister employing a polymeric film having improved moisture barrier properties
FR2895374B1 (en) 2005-12-27 2010-08-27 Valois Sas Ring aerosol valve.
US7445136B2 (en) * 2006-03-02 2008-11-04 Arlo Lin Valve for gas can
GB0614621D0 (en) * 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
US8344056B1 (en) 2007-04-04 2013-01-01 Homax Products, Inc. Aerosol dispensing systems, methods, and compositions for repairing interior structure surfaces
US9382060B1 (en) 2007-04-05 2016-07-05 Homax Products, Inc. Spray texture material compositions, systems, and methods with accelerated dry times
US8580349B1 (en) 2007-04-05 2013-11-12 Homax Products, Inc. Pigmented spray texture material compositions, systems, and methods
FR2918044B1 (en) * 2007-06-28 2012-01-20 Valois Sas Ring for a fluid dispensing valve.
US9242256B2 (en) * 2007-07-17 2016-01-26 S.C. Johnson & Son, Inc. Aerosol dispenser assembly having VOC-free propellant and dispensing mechanism therefor
US8221382B2 (en) 2007-08-01 2012-07-17 Hospira, Inc. Medicament admixing system
GB0719416D0 (en) * 2007-10-05 2007-11-14 3M Innovative Properties Co Metered dose valve
US8087548B2 (en) * 2008-05-14 2012-01-03 S.C. Johnson & Son, Inc. Spray products with particles and improved valve for inverted dispensing without clogging
GB2467579B (en) * 2009-02-06 2013-07-31 Consort Medical Plc Improvements in or relating to dispensing apparatus
DE102009022215B4 (en) * 2009-05-20 2011-06-22 LINDAL Dispenser GmbH, 23923 Valve for the metered delivery of liquids
FR2948645B1 (en) * 2009-07-30 2015-06-26 Valois Sas fluid dispenser valve
EP2482797B1 (en) * 2009-09-29 2018-09-12 Glaxo Group Limited Improvements to pressurised metered dose inhalers
CN105963694A (en) 2010-04-30 2016-09-28 阿雷克森制药公司 Anti-c5a antibodies and methods for using the antibodies
EP2585110A4 (en) 2010-06-22 2014-01-22 Univ Colorado Regents Antibodies to the c3d fragment of complement component 3
GB201018697D0 (en) 2010-11-05 2010-12-22 Reckitt & Colman Overseas Devices and methods for emanating liquids
US8721612B2 (en) 2010-12-17 2014-05-13 Hospira, Inc. System and method for intermixing the contents of two containers
US20120168460A1 (en) * 2010-12-30 2012-07-05 Boris Tolstykh Reusable dispensing valve for pressurized canisters
GB201110696D0 (en) * 2011-06-24 2011-08-10 Reckitt & Colman Overseas Devices and methods for emanating liquids
GB201110695D0 (en) * 2011-06-24 2011-08-10 Reckitt & Colman Overseas Devices and methods for emanating liquids
US9156042B2 (en) 2011-07-29 2015-10-13 Homax Products, Inc. Systems and methods for dispensing texture material using dual flow adjustment
US9248457B2 (en) 2011-07-29 2016-02-02 Homax Products, Inc. Systems and methods for dispensing texture material using dual flow adjustment
ES2660483T3 (en) 2011-10-03 2018-03-22 Hospira, Inc. System and method for mixing the contents of two containers
US9603907B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Dry powder formulations of dNase I
US9156602B1 (en) 2012-05-17 2015-10-13 Homax Products, Inc. Actuators for dispensers for texture material
WO2014043487A3 (en) 2012-09-14 2014-12-11 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
FR2996827B1 (en) * 2012-10-12 2014-10-31 Rexam Healthcare La Verpillier A metering valve for dispensing a aerosol
FR2993250B1 (en) 2012-10-12 2014-08-01 Rexam Healthcare La Verpillier A metering valve for dispensing a aerosol
FR3000945B1 (en) * 2013-01-15 2016-02-05 Lindal France metering valve
US9435120B2 (en) 2013-03-13 2016-09-06 Homax Products, Inc. Acoustic ceiling popcorn texture materials, systems, and methods
FR3006300B1 (en) * 2013-06-04 2015-07-03 Aptar France Sas metering valve and fluid dispenser device comprising such a valve.
US9776785B2 (en) 2013-08-19 2017-10-03 Ppg Architectural Finishes, Inc. Ceiling texture materials, systems, and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
FR3019535B1 (en) * 2014-04-02 2016-03-25 Rexam Healthcare La Verpillier Assembly for dispensing an aerosol having an enhanced area of ​​contact with a reservoir neck
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
USD787326S1 (en) 2014-12-09 2017-05-23 Ppg Architectural Finishes, Inc. Cap with actuator
GB2558522A (en) * 2016-06-20 2018-07-18 Kind Consumer Ltd A pressurised Container

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867352A (en) * 1988-04-05 1989-09-19 Philip Meshberg Dispensing valve assembly for use with a pressurized container
US4944433A (en) 1988-01-28 1990-07-31 Boehringer Ingelheim Kg Sediment baffle for valves of pressurized containers
US5037012A (en) 1989-07-28 1991-08-06 Harris Pharmaceuticals Limited Valve for an aerosol dispenser
US5632421A (en) * 1994-07-14 1997-05-27 Rexam Dispenser S.P.A. Aerosol metering valves
US5697532A (en) 1993-06-14 1997-12-16 Minnesota Mining And Manufacturing Company Metered-dose aerosol valves
US5904274A (en) 1996-09-03 1999-05-18 Bespak, Plc Metering valve
US6170717B1 (en) * 1996-12-27 2001-01-09 Glaxo Wellcome Inc. Valve for aerosol container

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB326122A (en) * 1929-08-06 1930-03-06 Ferdinand Robert Rosan Improvements in and relating to tools, applicable for rotating screws and other objects
US3176889A (en) * 1961-08-14 1965-04-06 Potapenko Gennady Pressurized dispenser with integral stem seal
US3841602A (en) * 1973-11-29 1974-10-15 W Mildern Valve
US3977576A (en) * 1975-02-24 1976-08-31 Arnaldo Amabili Spray can and valve construction
GB2004526B (en) * 1977-09-22 1982-07-28 Glaxo Group Ltd Aerosol valve
FR2450758B1 (en) * 1979-03-08 1986-01-17 Valois Sa valve mounting arrangement in a container aerosol
GB8312479D0 (en) 1983-05-06 1983-06-08 Riker Laboratories Inc Valve assembly
US4773553A (en) * 1985-09-12 1988-09-27 Risdon Corporation Assembly for securing and sealing a dispenser to a flanged container
GB8624670D0 (en) 1986-10-15 1986-11-19 Glaxo Group Ltd Valve for aerosol container
FR2615124B1 (en) * 1987-05-12 1989-11-24 Valois Aerosol metering valve has propellant used in reversed position
FR2615173B1 (en) * 1987-05-13 1989-08-18 Valois metering valve for liquid filler a liquid or liquefied gas propellant for use in an inverted position
GB8720978D0 (en) 1987-09-07 1987-10-14 Bespak Plc Collapsible chamber metering valve
GB8819490D0 (en) 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
GB8900670D0 (en) * 1989-01-12 1989-03-08 Microvol Ltd Pressurised metering dispenser
DE4018147A1 (en) * 1990-02-24 1991-08-29 Weener Plastik Gmbh Co Kg Ventilkoerper
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
GB9208881D0 (en) 1992-04-24 1992-06-10 Sullivan Howard M Metering valve for aerosols
FI95873C (en) 1992-10-15 1996-04-10 Orion Yhtymae Oy valve for use in connection with the inhaler
GB9305975D0 (en) 1993-03-23 1993-05-12 Minnesota Mining & Mfg Metered-dose aerosol valves
ES2119219T5 (en) 1993-07-15 2011-05-11 Minnesota Mining And Manufacturing Company seals for use in a device for supplying an aerosol.
US5474758A (en) 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
US5400920A (en) 1993-07-29 1995-03-28 Minnesota Mining And Manufacturing Company One-time fill aerosol valve
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
DE69314814T2 (en) 1993-08-31 1998-03-19 Praezisions Ventil Gmbh aerosol valve
US5348199A (en) 1993-09-13 1994-09-20 Summit Packaging Systems, Inc. Aerosol valve having means to shut off flow if valve is tipped beyond a certain inclination from vertical
US5421492A (en) 1993-11-02 1995-06-06 Glaxo Inc. Metered aerosol dispensing apparatus and method of use thereof
GB9420971D0 (en) 1994-05-06 1994-12-07 Minnesota Mining & Mfg Aerosol valves
DE4426821A1 (en) 1994-07-28 1996-02-01 Coster Tecnologie Speciali Spa A metering valve for dispensing pressurized fluids
DE4427175A1 (en) * 1994-08-01 1996-02-08 Coster Tecnologie Speciali Spa unit
DE4428365A1 (en) 1994-08-10 1996-02-15 Coster Tecnologie Speciali Spa Valve for the delivery of pressurized fluids
US5562219A (en) * 1994-09-22 1996-10-08 Valois, S.A. Device for attaching a dispenser member to a receptacle
FR2729436B1 (en) 1995-01-18 1997-04-04 Valois Pump intake valve piece and mold assembly of such a valve
GB2298187A (en) 1995-02-24 1996-08-28 Bespak Plc Metering valve
CA2213442A1 (en) 1995-03-10 1996-09-19 The Minnesota Mining & Manufacturing Company Aerosol valves
FR2740527B1 (en) * 1995-10-31 1998-01-02 Valois valve stem has low friction
GB2307224A (en) * 1995-11-15 1997-05-21 Bespak Plc Metered aerosol dispensing valve
GB2312418A (en) * 1996-04-26 1997-10-29 Bespak Plc Valves for dispensers
GB2329939A (en) * 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
DE19835273A1 (en) * 1997-09-03 1999-03-04 Bespak Plc Metering valve for pressurized dispensing containers
GB9918573D0 (en) * 1999-08-07 1999-10-06 Glaxo Group Ltd Valve

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944433A (en) 1988-01-28 1990-07-31 Boehringer Ingelheim Kg Sediment baffle for valves of pressurized containers
US4867352A (en) * 1988-04-05 1989-09-19 Philip Meshberg Dispensing valve assembly for use with a pressurized container
US5037012A (en) 1989-07-28 1991-08-06 Harris Pharmaceuticals Limited Valve for an aerosol dispenser
US5697532A (en) 1993-06-14 1997-12-16 Minnesota Mining And Manufacturing Company Metered-dose aerosol valves
US5632421A (en) * 1994-07-14 1997-05-27 Rexam Dispenser S.P.A. Aerosol metering valves
US5904274A (en) 1996-09-03 1999-05-18 Bespak, Plc Metering valve
US6170717B1 (en) * 1996-12-27 2001-01-09 Glaxo Wellcome Inc. Valve for aerosol container

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6510969B2 (en) * 1996-12-27 2003-01-28 Smithkline Beecham Corporation Valve for aerosol container
US7350676B2 (en) 1996-12-27 2008-04-01 Smithkline Beecham Corporation Valve for aerosol container
US20050183720A1 (en) * 1996-12-27 2005-08-25 Patrick Di Giovanni Valve for aerosol container
US6966467B2 (en) 1996-12-27 2005-11-22 Smithklinebeecham Corporation Valve for aerosol container
US6843392B1 (en) 1999-08-07 2005-01-18 Smith Kline Beecham Valve with a valve stem wiper
US6607106B2 (en) * 2001-07-09 2003-08-19 Conagra Dairy Food Research Center Aerosol valve
US20050173466A1 (en) * 2001-12-13 2005-08-11 David Goujon Fluid product dispensing valve and fluid product dispensing device comprising same
US7278556B2 (en) * 2001-12-13 2007-10-09 Valois S.A. Fluid product dispensing valve and fluid product dispensing device comprising same
US20060076010A1 (en) * 2002-12-18 2006-04-13 King Michael L Drug delivery system with vented mouthpiece
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US8172827B2 (en) 2003-05-13 2012-05-08 Innovative Pulmonary Solutions, Inc. Apparatus for treating asthma using neurotoxin
US20060243753A1 (en) * 2003-07-02 2006-11-02 David Goujon Control valve for a fluid product dispenser and a fluid product dispenser comprising such a valve
US20070053843A1 (en) * 2003-10-28 2007-03-08 Dawson Michelle L Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
US20050230451A1 (en) * 2004-04-19 2005-10-20 Vanstaan Valery H In-can fuel cell metering valve
US7571841B2 (en) 2004-04-19 2009-08-11 Illinois Tool Works, Inc. Interchangeable adapter for in-can and on-can fuel cells
US20080110953A1 (en) * 2004-04-19 2008-05-15 Gibson Eric S Interchangeable adapter for in-can and on-can fuel cells
US7392922B2 (en) * 2004-04-19 2008-07-01 Illinois Tool Works Inc. In-can fuel cell metering valve
US20090029901A1 (en) * 2005-02-10 2009-01-29 Marian Wood-Kaczmar Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations
US20090047351A1 (en) * 2005-02-10 2009-02-19 Stephen Newman Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom
US9365905B2 (en) 2005-02-10 2016-06-14 Dmv-Fonterra Excipients Technology Gmbh Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
EP3199164A1 (en) 2005-02-10 2017-08-02 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
US20070183982A1 (en) * 2006-02-09 2007-08-09 Erhard Berkel Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant
US9067031B2 (en) 2006-10-19 2015-06-30 3M Innovative Properties Company Metered dose valves and dispensers
WO2008049107A1 (en) * 2006-10-19 2008-04-24 3M Innovative Properties Company Metered dose valves and dispensers
US20100199983A1 (en) * 2006-10-19 2010-08-12 Jinks Philip A Metered dose valves and dispensers
US10124129B2 (en) 2008-01-02 2018-11-13 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US9125643B2 (en) 2008-02-15 2015-09-08 Holaira, Inc. System and method for bronchial dilation
US8731672B2 (en) 2008-02-15 2014-05-20 Holaira, Inc. System and method for bronchial dilation
US8489192B1 (en) 2008-02-15 2013-07-16 Holaira, Inc. System and method for bronchial dilation
US9668809B2 (en) 2008-05-09 2017-06-06 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8088127B2 (en) 2008-05-09 2012-01-03 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8226638B2 (en) 2008-05-09 2012-07-24 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961507B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961508B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8808280B2 (en) 2008-05-09 2014-08-19 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8821489B2 (en) 2008-05-09 2014-09-02 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US9381636B2 (en) * 2008-05-16 2016-07-05 Max Co., Ltd. Fuel cartridge and gas-combustion type driving tool
US20130320061A1 (en) * 2008-05-16 2013-12-05 Max Co., Ltd. Fuel cartridge and gas-combustion type driving tool
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US9682202B2 (en) 2009-05-18 2017-06-20 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
US9017324B2 (en) 2009-10-27 2015-04-28 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8777943B2 (en) 2009-10-27 2014-07-15 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9675412B2 (en) 2009-10-27 2017-06-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9649153B2 (en) 2009-10-27 2017-05-16 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9931162B2 (en) 2009-10-27 2018-04-03 Nuvaira, Inc. Delivery devices with coolable energy emitting assemblies
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9005195B2 (en) 2009-10-27 2015-04-14 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8932289B2 (en) 2009-10-27 2015-01-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9649154B2 (en) 2009-11-11 2017-05-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9724482B2 (en) 2009-11-25 2017-08-08 Boehringer Ingelheim International Gmbh Nebulizer
US10124125B2 (en) 2009-11-25 2018-11-13 Boehringer Ingelheim International Gmbh Nebulizer
US20120168463A1 (en) * 2009-12-01 2012-07-05 Toyo Aerosol Industry Co., Ltd. Aerosol device for allocation of plurality of fluids
US9038858B2 (en) * 2009-12-01 2015-05-26 Toyo Aerosol Industry Co., Ltd. Aerosol device for allocation of plurality of fluids
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
US20150122836A1 (en) * 2010-08-16 2015-05-07 Bayer Materialscience Ag Dispensing module
US20130161352A1 (en) * 2010-08-16 2013-06-27 Bayer Intellectual Property Gmbh Dispensing module
US9624021B2 (en) * 2010-08-16 2017-04-18 Covestro Deutschland Ag Dispensing module
WO2012041031A1 (en) 2010-09-28 2012-04-05 健乔信元医药生技股份有限公司 Compound composition for inhalation used for treating asthma
US9926130B2 (en) 2010-12-22 2018-03-27 Daizo Corporation Valve assembly and aerosol container equipped with the same, and aerosol product and process for production thereof
US9475636B2 (en) * 2010-12-22 2016-10-25 Daizo Corporation Valve assembly and aerosol container equipped with the same, and aerosol product and process for production thereof
US20140008389A1 (en) * 2010-12-22 2014-01-09 Satoshi Mekata Valve assembly and aerosol container equipped with the same, and aerosol product and process for production thereof
WO2013026269A1 (en) 2011-03-17 2013-02-28 益得生物科技股份有限公司 Method for preparing metered dose sprayed inhaler for treating respiratory disease
US9757750B2 (en) 2011-04-01 2017-09-12 Boehringer Ingelheim International Gmbh Medicinal device with container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US9545487B2 (en) 2012-04-13 2017-01-17 Boehringer Ingelheim International Gmbh Dispenser with encoding means
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US10004857B2 (en) 2013-08-09 2018-06-26 Boehringer Ingelheim International Gmbh Nebulizer
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
US10099022B2 (en) 2014-05-07 2018-10-16 Boehringer Ingelheim International Gmbh Nebulizer
US20170144285A1 (en) * 2015-11-25 2017-05-25 Illinois Tool Works Inc. Adapter for combustion tool fuel cells

Also Published As

Publication number Publication date Type
DK1145987T3 (en) 2004-06-28 grant
DE69728580D1 (en) 2004-05-13 grant
US20050183720A1 (en) 2005-08-25 application
DE69735247D1 (en) 2006-04-20 grant
DE69711710T2 (en) 2002-10-17 grant
ES2258753T3 (en) 2006-09-01 grant
DK958201T3 (en) grant
US20020082581A1 (en) 2002-06-27 application
JP3549543B2 (en) 2004-08-04 grant
JP4137700B2 (en) 2008-08-20 grant
US20030136802A1 (en) 2003-07-24 application
JP2003334474A (en) 2003-11-25 application
DK0958201T3 (en) 2002-07-29 grant
CA2391111A1 (en) 1998-07-09 application
ES2175515T3 (en) 2002-11-16 grant
US6510969B2 (en) 2003-01-28 grant
US7350676B2 (en) 2008-04-01 grant
EP1145987A1 (en) 2001-10-17 application
DE69735247T2 (en) 2006-11-23 grant
JP2000516898A (en) 2000-12-19 application
ES2220619T3 (en) 2004-12-16 grant
DE69728580T2 (en) 2005-03-03 grant
CN1241979A (en) 2000-01-19 application
CN1094876C (en) 2002-11-27 grant
KR100541308B1 (en) 2006-01-12 grant
CA2276163C (en) 2002-10-01 grant
EP0958201B1 (en) 2002-04-03 grant
EP1415934A1 (en) 2004-05-06 application
US6966467B2 (en) 2005-11-22 grant
WO1998029321A1 (en) 1998-07-09 application
KR20000069749A (en) 2000-11-25 application
EP0958201A1 (en) 1999-11-24 application
DK1415934T3 (en) 2006-06-06 grant
EP1415934B1 (en) 2006-02-15 grant
CA2276163A1 (en) 1998-07-09 application
US6170717B1 (en) 2001-01-09 grant
DE69711710D1 (en) 2002-05-08 grant
GB9626960D0 (en) 1997-02-12 application
EP1145987B1 (en) 2004-04-07 grant
CA2391111C (en) 2004-06-22 grant

Similar Documents

Publication Publication Date Title
Prime et al. Review of dry powder inhalers
US5143126A (en) Vibratory process and apparatus for agglomerating and metering non-flowable powders
US7258118B2 (en) Pharmaceutical powder cartridge, and inhaler equipped with same
US6640805B2 (en) Metering valve for a metered dose inhaler having improved flow
US6065472A (en) Multidose powder inhalation device
US6142145A (en) Inhalation device
US5593069A (en) Aerosol valves with movable agitator
US4667668A (en) Dosage inhalator
US6029663A (en) Dry powder inhaler delivery system
US7234464B2 (en) Storage system for powdered pharmaceuticals, and inhaler equipped with this system
US4819834A (en) Apparatus and methods for delivering a predetermined amount of a pressurized fluid
US6553987B1 (en) Dry powder inhaler
US6143277A (en) Metered dose inhaler for salmeterol
US6131566A (en) Metered dose inhaler for albuterol
US6284287B1 (en) Particulate formulation for administration by inhalation
US5772085A (en) Free flow aerosol valves
US5477992A (en) Metered-dose aerosol valves
US6149892A (en) Metered dose inhaler for beclomethasone dipropionate
US6253762B1 (en) Metered dose inhaler for fluticasone propionate
EP0069715B1 (en) Powder inhalator
US6076522A (en) Metering apparatus
US4944433A (en) Sediment baffle for valves of pressurized containers
US6926178B1 (en) Valve with a two-component seal
WO2005102429A1 (en) Inhaler
US6183782B1 (en) Inhalation composition containing lactose pellets

Legal Events

Date Code Title Description
AS Assignment

Owner name: SMITHKLINE BEECHAM CORPORATION, PENNSYLVANIA

Free format text: MERGER;ASSIGNOR:GLAXO WELLCOME INC.;REEL/FRAME:013277/0666

Effective date: 20010330

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12